NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Atara Biotherapeutics (ATRA) plans to cut around 50% of its workforce, just a little over a week after the FDA declined to ...

Short ATRA slightly under 8.11, target 4.38, stop loss @ 8.13 Check the time stamp on this data. Updated AI-Generated Signals ...

Atara Biotherapeutics has just announced a CRL by FDA for EBVALLO. Click here to read more about ATRA stock and why it is ...

The Advanced Technology Research Aircraft is equipped with the nose of a Eurofighter to test the new E-Scan Mk1 AESA radar, ...

Levi & Korsinsky notifies investors that it has commenced an investigation of Atara Biotherapeutics, Inc. ('Atara Biotherapeutics, Inc.') ...

Airbus has completion of a first flight for German Aerospace Center's (DLR) modified Airbus A320 ATRA for the E-Scan radar ...

HC Wainwright issued their FY2024 EPS estimates for Atara Biotherapeutics in a research note issued to investors on Wednesday, January 22nd. HC Wainwright analyst R. Burns forecasts that the ...

Airbus has flown the Advanced Technology Research Aircraft (ATRA) flight test aircraft (FTA) that has been modified for the ...

Atara stock plunges 41% upon the FDA issuance of a CRL against its BLA for Ebvallo to treat EBV+ PTLD. The company is also facing a severe cash crunch.

Atara Biotherapeutics, Inc.’s ATRA share price has dipped by 40.50%, which has investors questioning if this is right time to ...